Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout

Rheumatology International

Volumn 36, Issue 2, 2016, Pages 255-261

  Fatima, Tahzeeb ^a   Altaf, Sara ^a   Phipps Green, Amanda ^a   Topless, Ruth ^a   Flynn, Tanya J ^a   Stamp, Lisa K ^b   Dalbeth, Nicola ^c   Merriman, Tony R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

ADRB3; Association; Genetic; Gout; Urate

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; TRYPTOPHAN; URATE; URIC ACID; ADRB3 PROTEIN, HUMAN; BIOLOGICAL MARKER;

ALLELISM; ARTICLE; CONTROLLED STUDY; EUROPEAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GOUT; HUMAN; MAORI (PEOPLE); NEW ZEALAND; PACIFIC ISLANDER; POLYNESIAN; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HYPERURICEMIA; META ANALYSIS; MULTIVARIATE ANALYSIS; OCEANIC ANCESTRY GROUP; ODDS RATIO; PHENOTYPE; POLYNESIA; RISK FACTOR; STATISTICAL MODEL;

BIOMARKERS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; HYPERURICEMIA; LINEAR MODELS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; NEW ZEALAND; OCEANIC ANCESTRY GROUP; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; POLYNESIA; RECEPTORS, ADRENERGIC, BETA-3; RISK FACTORS; URIC ACID;

EID: 84955363348     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3370-6     Document Type: Article

References (32)

1. Dalbeth N, Merriman T (2009) Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatology 48:222–226
2. Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C et al (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45:145–154
3. Phipps-Green A, Merriman M, Topless R, Altaf S, Montgomery G, Franklin C et al (2014) Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann Rheum Dis. doi:10.1136/annrheumdis-2014-205877
4. Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120:442–447
5. Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Care Res 57:109–115
6. Facchini F, Chen Y-DI, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008–3011
7. Lyngdoh T, Vuistiner P, Marques-Vidal P, Rousson V, Waeber G, Vollenweider P et al (2012) Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS One 7:e39321
8. Rasheed H, Hughes K, Flynn TJ, Merriman TR (2014) Mendelian randomisation provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Circ Cardiovasc Genet 7:830–837
9. Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P et al (1993) Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 91:344–349
10. Kurokawa N, Young EH, Oka Y, Satoh H, Wareham NJ, Sandhu M et al (2008) The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44,833 individuals. Int J Obes 32:1240–1249
11. Gjesing A, Andersen G, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O (2008) Association of the β3-adrenergic receptor Trp64Arg polymorphism with common metabolic traits: studies of 7605 middle-aged white people. Mol Genet Metab 94:90–97
12. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995) Association of a polymorphism in the β3-adrenergic–receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348–352
13. Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G et al (2001) Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 19:399–406
14. Wang G, Li Q, Niu T, Chen C, Xu X (2002) Association of GYS1 and beta (3)-AR gene with postprandial hyperglycemia and serum uric acid in type 2 diabetes mellitus. Chin Med J 115:1308–1311
15. Rho YH, Choi SJ, Lee YH, Ji JD, Song GG (2007) The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptor. Rheumatol Int 27:835–839
16. Huang Q, Zhang L-F, Cheng Y, Zhao Y-C, Si L, Gao Y et al (2013) Trp64Arg (rs4994) polymorphism of β3-adrenergic receptor gene is associated with hyperuricemia in a Chinese male population. Clin Chem Lab Med 51:1755–1760
17. Morcillo S, Rojo-Martínez G, Martín-Núñez GM, Gómez-Zumaquero JM, García-Fuentes E, de Adana MR et al (2010) Trp64Arg polymorphism of the ADRB3 gene predicts hyperuricemia risk in a population from southern Spain. J Rheumatol 37:417–421
18. Wang B, Meng D, Wang J, Jia Z, Zhoub S, Liu S et al (2011) Positive correlation between Beta-3-Adrenergic Receptor (ADRB3) gene and gout in a Chinese male population. J Rheumatol 38:738–740
19. Winnard D, Wright C, Jackson G, Gow P, Kerr A, McLachlan A et al (2013) Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. NZ Med J. 126:53–64
20. Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ et al (2012) National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatol 51:901–909
21. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895–900
22. Hollis-Moffatt JE, Phipps-Green AJ, Chapman B, Jones GT, van Rij A, Gow PJ et al (2012) The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther 14:R92
23. Howie B, Marchini J, Stephens M (2011) Genotype imputation with thousands of genomes. G3: genes, genomes. Genetics 1:457–470
24. Team RC (2012) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. ISBN 3-900051-07-0
25. Phipps-Green AJ, Hollis-Moffatt J, Dalbeth N, Merriman ME, Topless R, Gow PJ et al (2010) A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet 19:4813–4819
26. Savage DB, Petersen KF, Shulman GI (2005) Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45:828–833
27. Park HS, Shin ES, Lee JE (2008) Genotypes and haplotypes of β2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents. Metabolism 57:1064–1070
28. Zhan S, Ho SC (2005) Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with insulin resistance. Obes Res 13:1709–1719
29. Mark A, Rahmouni K, Correia M, Haynes W (2003) A leptin-sympathetic-leptin feedback loop: potential implications for regulation of arterial pressure and body fat. Acta Physiol Scand 177:345–349
30. Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44:527–536
31. Modan M, Halkin H, Karasik A, Lusky A (1987) Elevated serum uric acid—a facet of hyperinsulinaemia. Diabetologia 30:713–718
32. Quiñones-Galvan A, Ferrannini E (1996) Renal effects of insulin in man. J Nephrol 10:188–191